Company Comparison
Fulcrum Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Fulcrum Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | South San Francisco, California |
| Founded | 2016 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $200M | — |
| Valuation | — | — |
What They Build
Fulcrum Therapeutics
Clinical-stage biopharmaceutical company developing small molecule drugs for genetically defined diseases using gene modulation approach.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Fulcrum Therapeutics
Sector Overlap
Both Fulcrum Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →